InMed Pharmaceuticals; Revenue and Competitors
Estimated Revenue & Valuation
- InMed Pharmaceuticals;'s estimated annual revenue is currently $3.1M per year.
- InMed Pharmaceuticals;'s estimated revenue per employee is $155,000
Employee Data
- InMed Pharmaceuticals; has 20 Employees.
- InMed Pharmaceuticals; grew their employee count by -5% last year.
InMed Pharmaceuticals;'s People
Name | Title | Email/Phone |
---|---|---|
1 | VP Preclinical R&D | Reveal Email/Phone |
2 | VP, Investor Relations and Corporate Communications | Reveal Email/Phone |
3 | SVP, Clinical & Regulatory Affairs | Reveal Email/Phone |
4 | SVP | Reveal Email/Phone |
5 | VP, Chemistry, Manufacturing & Controls | Reveal Email/Phone |
6 | CEO + President, Director | Reveal Email/Phone |
7 | Senior Scientist | Reveal Email/Phone |
InMed Pharmaceuticals; Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $3.1M | 40 | 18% | $40M | N/A |
#2 | $0.2M | 2 | 0% | N/A | N/A |
#3 | $1.3M | 17 | -15% | N/A | N/A |
#4 | $2.6M | 17 | 6% | N/A | N/A |
#5 | $12.9M | 83 | 5% | N/A | N/A |
#6 | $1.9M | 24 | 4% | $89.5M | N/A |
#7 | $2.8M | 18 | 6% | N/A | N/A |
#8 | $40.3M | 260 | 21% | N/A | N/A |
#9 | $0.9M | 6 | 0% | N/A | N/A |
#10 | $0.6M | 4 | -20% | N/A | N/A |
What Is InMed Pharmaceuticals;?
InMed is a clinical stage biopharmaceutical company that specializes in developing novel therapies through the research and development into the extensive pharmacology of cannabinoids coupled with innovative drug delivery systems. InMed's proprietary platform technology, product pipeline and accelerated development pathway are the fundamental value drivers of the company.
keywords:N/AN/A
Total Funding
20
Number of Employees
$3.1M
Revenue (est)
-5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.1M | 20 | -9% | N/A |
#2 | $2M | 20 | N/A | N/A |
#3 | $2M | 20 | N/A | N/A |
#4 | $2.9M | 20 | 11% | N/A |
#5 | $2M | 20 | 0% | N/A |